Harbor Capital Advisors, Inc. Verve Therapeutics, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 29,959 shares of VERV stock, worth $224,093. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,959
Previous 30,019
0.2%
Holding current value
$224,093
Previous $399,000
63.41%
% of portfolio
0.01%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding VERV
# of Institutions
168Shares Held
76.9MCall Options Held
125KPut Options Held
185K-
Alphabet Inc. Mountain View, CA12.3MShares$92.4 Million7.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.33MShares$47.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.04MShares$45.2 Million0.57% of portfolio
-
Black Rock Inc. New York, NY5.37MShares$40.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.1MShares$38.1 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $448M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...